INSM
Insmed Incorporated
Stock
$111.12+2.53 (+2.33%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$779M | −$935M | −$684M | −$536M | −$400M | −$363M | −$219M | −$251M | −$258M | −$160M | −$147M | −$101M | −$64M | −$47M | −$31M | −$30M | −$7.7M | −$11M |
| Capital expenditures | $29M | $33M | $22M | $13M | $9.9M | $7.3M | $6.2M | $42M | $13M | $3.0M | $4.2M | $3.5M | $5.4M | $826K | $290K | $979K | $0 | $0 |
| Free cash flow | −$808M | −$968M | −$706M | −$550M | −$410M | −$371M | −$226M | −$293M | −$271M | −$163M | −$151M | −$104M | −$70M | −$47M | −$31M | −$31M | −$7.7M | −$11M |
| Stock-based compensation | $157M | $153M | $97M | $75M | $58M | $46M | $36M | $27M | $26M | $18M | $18M | $16M | $11M | $8.7M | $3.0M | $1.6M | $366K | $2.5M |
| Free cash flow margin | −71.0% | −159.6% | −194.1% | −180.1% | −167.2% | −196.6% | −137.2% | −214.6% | −2,756.1% | — | — | — | — | −413.0% | — | −706.0% | −111.6% | −106.2% |